Legal Representation
Attorney
Andrew S. Ehard
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 12, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Sep 12, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 26, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Jul 7, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jul 7, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Mar 29, 2025 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Feb 28, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 26, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 7, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 7, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 7, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 1, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Apr 9, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Apr 9, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 21, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 20, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 14, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 16, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 12, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 9, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Radioactive elements for scientific purposes; radioactive preparations for scientific purposes; chemicals for use in the manufacture of radiopharmaceutical products; chemical products for radioactive labelling
Class 005
Chemicals for pharmaceutical use in the nature of chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer and diseases associated with cellular proliferation; pharmaceutical drugs for the treatment of cancer and diseases associated with cellular proliferation; Pharmaceutical preparations for the treatment of cancer and diseases associated with cellular proliferation; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products, namely, radiopharmaceutical diagnostic preparations and radiopharmaceutical treatment preparations for the treatment of cancer and diseases associated with cellular proliferation; chemicals for radiopharmaceuticals for diagnostic uses; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radiopharmaceutical products for diagnostic uses; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; radioactive elements, isotopes, preparations and reagents for radioactive labelling of pharmaceutical products; Diagnostic radiopharmaceutical preparations
Class 010
Apparatus for administering pharmaceuticals for the treatment, prevention, or diagnosis of cancer, namely, medical apparatus for introducing pharmaceutical preparations into the human body for the treatment, prevention, or diagnosis of cancer; apparatus for medical purposes for the treatment, prevention, or diagnosis of cancer, namely, injection needles, injection syringes, and radiological apparatus for the treatment, prevention, or diagnosis of cancer; medical apparatus for the treatment of cancer; diagnostic imaging apparatus for medical use; pharmaceutical instruments, namely, radiological apparatus for medical purposes, medical apparatus for the treatment of cancer and diseases associated with cellular proliferation, and imaging apparatus for medical use for diagnosing medical conditions; applicators for pharmaceutical preparations, namely, applicators for pharmaceutical preparations sold without medication
Class 035
Advertising services; business advisory services relating to product development; business consultancy; retail and wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; intermediary business services relating to the commercialization of goods, namely, procuring of contracts for third parties for the purchase and sale of goods
Class 040
Custom manufacture of pharmaceuticals, namely, radiopharmaceuticals; Custom manufacture of pharmaceuticals, namely, radiolabelling of pharmaceuticals
Class 042
Provision of scientific information in the field of pharmaceuticals and clinical trials; scientific and technical analysis, namely, scientific research analysis in the field of pharmaceuticals; scientific consultancy; scientific research; scientific research in the field of pharmacy; medical research; research and development of products; laboratory research relating to pharmaceuticals; advisory services being product development consultation relating to immunological products; research and development of new techniques for radiolabelling of pharmaceutical products
Class 045
Exploitation of intellectual property rights, namely, licensing of intellectual property rights; licensing of intellectual property
Classification
International Classes
001
005
010
035
040
042
045